References

Menstrual Pain

SALOME™ MENSTRUAL PAIN

  1. Osayande AS, Mehulic S. Diagnosis and Initial Management of Dysmenorrhoea. Am Fam Physician. 2014;89(5):341-346.
  2. Jenabi E, Fereidoony B. Effect of Achillea Millefolium on Relief of Primary Dysmenorrhoea: A Double-Blind Randomized Clinical Trial. Journal of pediatric and adolescent gynaecology. 2015; 28: 402-404
  3. Radfar S, Shahoie R, Noori B, et al. Comparative Study on the Effect of Matricaria chamomile and Achillea MillefoliumCapsules on Primary Dysmenorrhoea Intensity of Dormitory Students of Kurdistan University of Medical Sciences, 2018. Journal of Pharmaceutical Research International. 2018;25(3): 1-7
  4. SALOME MENSTRUAL PAIN professional information.

 

Complementary Medicine: D33.6 Western Herbal Medicine.
SALOME™  MENSTRUAL PAIN. Each capsule contains Yarrow Dry extract Ratio 4:1 [Achillea millefolium L.] 250 mg.
This unregistered medicine has not been evaluated by SAHPRA for its quality, safety or intended use.

SALOME™ HEAVY MENSTRUAL BLEEDING

  1. Naafe M, Kariman N, Keshavarz Z, et al. The effect of Hydroalcoholic Extracts of Capsella Bursa-Pastoris on Heavy Menstrual Bleeding: A Randomized Clinical Trial. Journal of Alternative and Complementary Medicine March 2018, 1-7. DOI: 10.1089/acm.2017.0267
  2. SALOME® HEAVY MENSTRUAL BLEEDING professional information.
  3. Medscape. Menorrhagia. [Online] [20 Dec 2018] Accessed 11 Feb 2021. Available from: https://emedicine.medscape.com/article/255540-print.

Complementary Medicine: D33.6 Western Herbal Medicine.

SALOME®HEAVY MENSTRUAL BLEEDING. Each capsule contains Shepherd’s Purse Dry Extract 2% Polyphenols [Capsella bursa-pastoris (L) Medikus] 400 mg.

This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.

Polycos

SALOME™ POLYCOS

  1. SALOME® POLYCOS PI/PIL.
  2. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. Copyright Monash University, Melbourne
  3. Australia 2018. Available from: monash.edu/medicine/sphpm/mchri/pcos.
  4. Pizzo A, Laganà AS, Barbaro L. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Gynaecol Endocrinol, 2014; 30(3):205-208.
  5. Formuso C, Stracquadanio M, Ciotta L. Myo-Inositol vs D-Chiro-Inositol in PCOS Treatment. Minerva Ginecol. 2015;67(4):321-5.
  6. Nestler JE, Jakubowicz DJ, Reamer Pet al. Ovulatory and Metabolic Effects of D-Chiro-Inositol in the Polycystic Ovary Syndrome.
    N Engl J Med. 1999;340:1314-1320.
  7. Benelli E, Del Ghianda S, Di Cosmo C, Tonacchera M. A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Over-weight Women. International Journal of Endocrinology, Volume 2016, Article ID 3204083, 5 pages http://dx.doi.org/10.1155/2016/3204083
  8. La Marca A, Grisendi V, Dondi G, et al. The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study. Gynecol
  9. Dupont J, Scaramuzzi RJ. Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle. Biochem. J. 2016;473, 1483-1501.
  10. Menachini D, Facchinetti F. Myoinositol: mechanisms of action and role in the treatment of metabolic diseases, infertility and polycystic ovary syndrome.
    Nutrafoods. 2017:16:147-151. DOI 10.17470/NF-017-1008-3
  11. Cheang KI, Baillargeon J-P, Essah PA, Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator Correlates with Insulin Sensitivity in Women with Polycystic Ovary Syndrome. Metabolism. 2008;57(10):1390-1397.
  12. Larner J. D-Chiro-Inositol – Its Functional Role in Insulin Action and Its Deficit in Insulin Resistance. Int. Jnl. Experimental Diab. Res., 2002;3:47-60.
  13. luorno MJ, Jakubowicz DJ, Baillargeon J-P, et al. Effects of D-Chiro-Inositol in Lean Women with the Polycystic Ovary Syndrome. Endocr Pract. 2002;8:417-423.
  14. Piomboni P, Focarelli R, Capaldo A, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31:1269-1276

 

Complementary Medicine: Health Supplement D34.12 Multiple substance formulation.

Salome POLYCOS. Each capsule contains D-chiro-inositol 600mg.

This registered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.

m-pause

SALOME™ M-PAUSE

  1. SALOME® M-PAUSE Professional Information
  2. Stracquadanio M, Giunta MR, D’Agati A, et al. Efficacy of a New Compound Containing Cimicifuga Racemosa on Menopausal Symptoms in Women with Breast Cancer. Gynecol Obstet. 2017; 7:8. DOI: 10.4172/2161-0932.1000448
  3. Australian Menopause Society. Health Professionals. GP & HP Resources. Diagnosing Menopause [Online] January 2016. Accessed 28 October 2021.
  4. Available from: https://www.menopause.org.au/hp/gp-hp-resources/diagnosing-menopause
  5. Tao MF, Shao HF, Li CB, Teng YC. Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women.
  6. Patient Prefer Adherence. 2013;7:223-229.
  7. Fahami F, Asali Z, Aslani A, Fathizadeh N. A comparative study on the effects of Hypericum Perforatum and passionflower on the menopausal symptoms of women referring to Isfahan city health care centers. Iran J Nurs Midwifery Res. 2010 Autumn; 15(4): 202-207
  8. Chung DJ, Kim HY, Park KH, et al. Black cohosh and St. John’s wort (GYNO-Plus) for climacteric symptoms. Yonsei Med J. 2007 Apr 30;48(2):289-94

Complementary Medicine: D33.6 Western Herbal Medicine.

SALOME® M-PAUSE. Each capsule contains dry extract of Hypericum perforatum L., herba (St Johns Wort) 300 mg and dry extract of Cimicifuga racemosa (L.)

Nutt., rhizome(Black cohosh rhizome) 6,4 mg

This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.

SALOME™ PreMenS

  1. SALOME® PreMenS Professional Information
  2. Malik R, Bhat MDA. The management of Premenstrual syndrome: A review Bangladesh Journal of Medical Science, 2018;17(1):16-20.
  3. Tania Flack. Natural health solutions. Hold the Chocolate! – Why you get PMS and what you can do about it. [Online] 05/11/2012. Accessed 19 October 2021.
  4. Available from: https://www.taniaflack.com/general/hold-the-chocolate-why-you-get-pms-and-what-you-can-do-about-it/
  5. Abu Alwafa R, Badrasawi M, Hamad R. Prevalence of premenstrual syndrome and its association with psychosocial and lifestyle variables: a cross-sectional study from Palestine. BMC Women’s Health. 2021;21:233. https://doi.org/10.1186/s12905-021-01374-6
  6. Healthline. PMS (Premenstrual Syndrome) [Onlinel 11 May 2019. Accessed 19 October 2021. Available from: https://www.healthline.com/health/ premenstrual-syndrome#treatment
  7. Daniele C, Thompson Coon J, Pittler MH, Ernst E. Vitex agnus castus: A Systematic Review of Adverse Events. Drug Safety 2005;28(4):319-32.
  8. Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med. 2000 Apr;9(3):315-20. doi: 10.1089/152460900318515.
  9. Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.
  10. Arch Womens Ment Health 2017: 20:713-719.

 

Complementary Medicine: D33.6 Western Herbal Medicine.

SALOME® PreMenS. Each capsule contains dry extract of Vitex agnus-castus L., fructus (Chaste tree fruit) 4 mg

This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.

Flu Artem

References:

  1. Arentz, S., Hunter, J., Yang, G., Goldenberg, J., Beardsley, J., Myers, S. P., Mertz, D., & Leeder, S . (2020). Zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections: Advances in integrative Medicine, 7(4), 252-260. https://doi.org/10.1016/j.aimed.2020.07.009
  2. Science, M., Johnstone, J., Roth, D. E, Guyatt, G, & Loeb, M. (2012). Zinc for the treatment of the common cold: A systematic review and meta-analysis of randomized controlled trials. Canadian Medical Association Journal, 184(10), E561-E561. https://doi.org/10.1503/cmaj. 111990
  3. Van Wyk, B. -E., & Albrecht, C. (2008). A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). Joural of Ethnopharmacology, 119(3), 620-629. https://dol.org/10.1016/j.jep 2008.07.033
  4. Aboyade, O. M.,Slyger, G., Gibson, D., & Hughes, G. (2014). Sutherlandia frutescens: The meeting of science and traditional knowledge. Journal of Alternative and Complenmentary Medicine, 20(1), 71-76. https://dol.org/10.1089/acm.2013.0109
  5. Femandes, A. C.,Cromarty, A. D., Albrecht C & Jansen van Rensburg, C.E (2004). The antioxidant potential of Sutherlandia frutescens. Journal of Ethnopharmacology. 95(1), 1-5. https://doi.org/10.1016/j.jep.2004.06.011
  6. Esposito, G., Pesce, M., Segella, L., & Sanseverino, W. (2020).Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol a s a potential anti-inflammatory treatment? Frontiers in Immunology, 11, 586-737. https://doi.org/10.3389/fimmu.2020.586737
  7. Vallée, A. (20 gy Reports, 41. https://dcl.org/10.1016/j.btre.2024.e00329

Nullam quis risus eget urna mollis ornare vel eu leo. Aenean lacinia bibendum nulla sed 

  • @hormonix
Facebook-f Twitter Instagram Youtube